Pfizer, BioNTech Ask FDA to Authorize Their Covid-19 Vaccine

Pfizer Inc. and partner BioNTech SE asked U.S. health regulators on Friday to permit use of their Covid-19 vaccine, a milepost in months of frantic efforts to find a medicine that could beat back a rampaging pandemic.

Now it will be up to the U.S. Food and Drug Administration to decide whether the two-shot vaccine works safely enough to roll out to millions of people.


Related posts

Texas Attorney General’s Legal Woes Potentially Hinder Google Case


Xiaomi’s Gain at Huawei’s Expense Might Not Last


Measures of Chinese Economic Activity Signal Widening Recovery


Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More